{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:40:07Z","timestamp":1791283207361,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100013560","name":"GBS-CIDP Foundation International","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013560","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Talecris Talents program"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec><jats:title>Background and purpose<\/jats:title><jats:p>There is increasing interest in using patient\u2010reported outcome measures (<jats:styled-content style=\"fixed-case\">PROM<\/jats:styled-content>s) in clinical studies to capture individual changes over time. However, <jats:styled-content style=\"fixed-case\">PROM<\/jats:styled-content>s have also been criticized because they are entirely subjective. Our objective was to examine the relationship between a subjective <jats:styled-content style=\"fixed-case\">PROM<\/jats:styled-content> and an objective outcome tool in patients with Guillain\u2013Barr\u00e9 syndrome (<jats:styled-content style=\"fixed-case\">GBS<\/jats:styled-content>), chronic inflammatory demyelinating polyradiculoneuropathy (<jats:styled-content style=\"fixed-case\">CIDP<\/jats:styled-content>) and gammopathy\u2010related polyneuropathy (<jats:styled-content style=\"fixed-case\">MGUSP<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Inflammatory Rasch\u2010built Overall Disability Scale (I\u2010<jats:styled-content style=\"fixed-case\">RODS<\/jats:styled-content>\u00a9, a multi\u2010item scale that examines functionality) was completed by 137 patients with newly diagnosed (or relapsing) <jats:styled-content style=\"fixed-case\">GBS<\/jats:styled-content> (55), <jats:styled-content style=\"fixed-case\">CIDP<\/jats:styled-content> (59) and <jats:styled-content style=\"fixed-case\">MGUSP<\/jats:styled-content> (23) who were serially examined (<jats:styled-content style=\"fixed-case\">GBS<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CIDP<\/jats:styled-content>, T0\/T1\/T3\/T6\/T12 months; <jats:styled-content style=\"fixed-case\">MGUSP<\/jats:styled-content>, T0\/T3\/T12). Possible association between the I\u2010<jats:styled-content style=\"fixed-case\">RODS<\/jats:styled-content> findings and the vigorimeter scores, an objective linear instrument to assess grip strength, was examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A significant correlating trend was found between the I\u2010<jats:styled-content style=\"fixed-case\">RODS<\/jats:styled-content> and grip strength scores for the overall group and in each illness, independently.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The objectivity of patients' subjective report on their functional state based on a strong correlation between the I\u2010<jats:styled-content style=\"fixed-case\">RODS<\/jats:styled-content> and grip strength in patients with <jats:styled-content style=\"fixed-case\">GBS<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> CIDP<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MGUSP<\/jats:styled-content> has been demonstrated. These findings provide further support to use the I\u2010<jats:styled-content style=\"fixed-case\">RODS<\/jats:styled-content> and grip strength in future clinical studies in these conditions.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ene.13025","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T17:40:06Z","timestamp":1462038006000},"page":"1248-1253","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Correlation of the patient's reported outcome Inflammatory\u2010<scp>RODS<\/scp> with an objective metric in immune\u2010mediated neuropathies"],"prefix":"10.1111","volume":"23","author":[{"given":"T. H. P.","family":"Draak","sequence":"first","affiliation":[{"name":"Department of Neurology University Medical Centre Maastricht Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. C.","family":"Gorson","sequence":"additional","affiliation":[{"name":"Department of Neurology St Elizabeth's Medical Centre Tufts University School of Medicine Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. K.","family":"Vanhoutte","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics Maastricht University Medical Centre Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. I.","family":"van Nes","sequence":"additional","affiliation":[{"name":"Department of Neurology Havenziekenhuis Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"van Doorn","sequence":"additional","affiliation":[{"name":"Department of Neurology Erasmus Medical Centre Rotterdam Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Cornblath","sequence":"additional","affiliation":[{"name":"Department of Neurology Johns Hopkins School of Medicine Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. H.","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Department of Neurology Rudolf Magnus Institute of Neuroscience University Medical Centre Utrecht Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2467-067X","authenticated-orcid":false,"given":"C. G.","family":"Faber","sequence":"additional","affiliation":[{"name":"Department of Neurology University Medical Centre Maastricht Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. S. J.","family":"Merkies","sequence":"additional","affiliation":[{"name":"Department of Neurology University Medical Centre Maastricht Maastricht The Netherlands"},{"name":"Department of Neurology Spaarne Hospital Hoofddorp The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the PeriNomS Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"(USDHHS) UDoHaHS.Guidance for industry. Patient\u2010Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims 2009.http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatory%20Information\/Guidances\/UCM193282.pdf(accessed 8\/11\/2015)."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0911494"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2004.09.003"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-4-94"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-010-9677-6"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9990-8"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/09638237.2012.734653"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-86"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00275.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110216"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318208824b"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.06.006"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001044"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03851.x"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4598(200009)23:9<1393::AID-MUS10>3.0.CO;2-O"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70329-0"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12007"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2008.00169.x"},{"key":"e_1_2_7_21_1","first-page":"617","article-title":"Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","volume":"41","author":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)","year":"1991","journal-title":"Neurology"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707"},{"key":"e_1_2_7_23_1","first-page":"219","article-title":"Paraproteinaemic neuropathies","volume":"5","author":"Miescher GC","year":"1996","journal-title":"Baillieres Clin Neurol"},{"key":"e_1_2_7_24_1","first-page":"385","volume-title":"Statistical Models for Longitudinal Studies of Health","author":"Dwyer JFM","year":"1992"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jns5.12017"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1986.tb03331.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.52.11.1267"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23108"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12118"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2013.02.328"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fene.13025","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.13025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T10:02:19Z","timestamp":1695549739000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.13025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1111\/ene.13025"],"URL":"https:\/\/doi.org\/10.1111\/ene.13025","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]},"assertion":[{"value":"2016-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-03-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}